COVID-19 (Virus named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) is a pandemic
disease characterized with respiratory infection caused by coronavirus. It has worldwide after an outbreak began in Wuhan,
China, in December 2019. SARS-CoV-2 has infected more than 15 million people globally. The disease severity and
mortality increased in patients with heart-related comorbidities. Cardiovascular disease patients are more susceptible and
infected with SARS-CoV-2. Early screening and managements these patients prevent or ameliorate adverse outcomes.
Several treatments have been used to combat these effects as previously seen in MERS and SARS. This review will cover
the association of cardiovascular diseases with COVID 19. It showed that cardiovascular diseases are common in patients
with COVID- 19. Increased attention to highlight the gaps should be paid to the care of this unique group of patients.
Keywords: COVID-19, SARS-CoV-2, cardiovascular, treatment, heart disease, hypertension.
Rights & PermissionsPrintExport